Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Prednisolone
Prednisolone
Routinely available
Local application
28/09/2022
Indication
Idiopathic pulmonary fibrosis (IPF) and other chronic fibrosing interstitial lung diseases.
Therapeutic Area
Respiratory system
Status Description
Routinely available in line with local or regional guidance
Formulation
Tablet
Comments
September 2022 - Routinely available in line with local or regional guidance. Included on the ERF specialist initiation.